Bill Text: IL SR0136 | 2023-2024 | 103rd General Assembly | Introduced

---

Bill Title: Urges the Centers for Disease Control and Prevention to include new RSV immunization technologies (including vaccines and monoclonal antibodies), within the federal VFC program if the Advisory Committee on Immunization Practices of the Centers for Disease Control and Prevention issues administrative recommendations that are subsequently approved by the Director of the Centers for Disease Control and Prevention.

Spectrum: Partisan Bill (Democrat 2-0)

Status: (Passed) 2023-05-19 - Resolution Adopted [SR0136 Detail]

Download: Illinois-2023-SR0136-Introduced.html

---

SR0136 LRB103 31458 MST 59199 r
SENATE RESOLUTION
WHEREAS, Respiratory Syncytial Virus disease (RSV) is a
highly transmissible, seasonal virus that can have severe and
unpredictable outcomes for infants, including hospitalization;
and
WHEREAS, Nearly all children will be infected with RSV by
age two, and most infants requiring hospitalization were
previously healthy and born at term; and
WHEREAS, RSV is the leading cause of hospitalization among
infants in the U.S.; and
WHEREAS, RSV is the most common cause of bronchiolitis
(inflammation of the small airways in the lung) and pneumonia
(infection of the lungs) in children younger than one year of
age in the U.S.; and
WHEREAS, The current RSV season has resulted in
significant morbidity and increased mortality; and
WHEREAS, In the U.S., RSV infections typically occur
during late fall, winter, and early spring, which means urgent
preparation is needed; and

SR0136 - 2 - LRB103 31458 MST 59199 r
WHEREAS, Monoclonal antibodies show promise in
preventative protection against RSV; and
WHEREAS, RSV disproportionally affects infants with
Medicaid coverage, Native Americans, and Alaskan Natives; and
WHEREAS, The Vaccines For Children (VFC) program is a
federally-funded program that provides vaccines at no cost to
children who might not otherwise be vaccinated because of
inability to pay; and
WHEREAS, VFC coverage is critical to ensure equity and
access for all infants in order to have the greatest impact on
disease burden; therefore, be it
RESOLVED, BY THE SENATE OF THE ONE HUNDRED THIRD GENERAL
ASSEMBLY OF THE STATE OF ILLINOIS, that we urge the Centers for
Disease Control and Prevention to include new RSV immunization
technologies (including vaccines and monoclonal antibodies),
within the federal VFC program if the Advisory Committee on
Immunization Practices of the Centers for Disease Control and
Prevention issues administrative recommendations that are
subsequently approved by the Director of the Centers for
Disease Control and Prevention; and be it further
RESOLVED, That suitable copies of this resolution be

SR0136 - 3 - LRB103 31458 MST 59199 r
delivered to Director of the Centers for Disease Control and
Prevention Rochelle Walensky, Administrator of the Centers for
Medicare and Medicaid Services (CMS) Chiquita Brooks-LaSure,
and Secretary of the Department of Health and Human Services
Xavier Becerra.